Global Information
회사소개 | 문의

세계의 애완동물용 암 치료제 시장 동향과 예측

Pet Cancer Therapeutics Market, by Therapy Type, Pet Type, Mode of Administration, Application, and Region - Global Trends, and Forecast till 2025

리서치사 Coherent Market Insights
발행일 2018년 02월 상품 코드 604420
페이지 정보 영문 195 Pages
가격
US $ 4,500 ₩ 5,134,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 7,986,300 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,409,000 PPT Turned PDF (Enterprise User License)


세계의 애완동물용 암 치료제 시장 동향과 예측 Pet Cancer Therapeutics Market, by Therapy Type, Pet Type, Mode of Administration, Application, and Region - Global Trends, and Forecast till 2025
발행일: 2018년 02월 페이지 정보 : 영문 195 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

세계의 애완동물용 암 치료제(Pet Cancer Therapeutics) 시장에 대해 조사했으며, 시장 현황과 향후 발전 동향, 부문별 동향, 주요 진출 기업 개요 등의 정보를 전해드립니다.

제1장 조사 목적과 가정

제2장 시장 개요

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
  • 주요 하이라이트
  • 파이프라인 분석
  • 규제 가이드라인
  • 애완동물의 암 예방 계획
  • 애완동물의 암에 대해 승인된 표적요법
  • 역학

제4장 치료 유형별 시장

  • 서론
  • 화학요법
  • 표적요법
  • 병용요법
  • 면역요법

제5장 애완동물 종류별 시장

  • 서론
  • 고양이

제6장 투여 방법별 시장

  • 서론
  • 경구
  • 정맥주사
  • 국소

제7장 용도별 시장

  • 서론
  • 림프종
  • 비만세포암
  • 흑색종
  • 유선세포암 및 편평세포암
  • 기타

제8장 지역별 시장

  • 서론
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제9장 경쟁 상황

  • 히트맵 분석
  • 시장 점유율 분석
  • 기업 개요
  • 애널리스트의 견해

제10장 섹션

KSM 18.02.27

영문목차

The pet cancer therapeutics include chemotherapy drugs, targeted therapies, combination therapies, and immunotherapy vaccines, which are commonly recommended by the veterinary doctors. The drugs are mostly recommended to treat various conditions such as lymphoma, mast cell tumors, fibrosarcoma, hemangiosarcoma, and others. Currently, a wide range of formulations are available in the global market for the treatment of pet cancers, which can be administered in the form of tablets, injections or can be applied topically. Thus, the large variety of treatment options has made it easy for the pets to receive effective cancer treatment suitable to curb the condition.

Market Dynamics

The major factor driving growth of the pet cancer therapeutics market include robust number of pipeline drugs for the treatment of highly prevalent conditions such as lymphoma and melanoma. For instance, in 2017, Aratana Therapeutics received approval from the United States Department of Agriculture (USDA) Center for Veterinary Biologics for canine osteosarcoma vaccine- AT-014 for the treatment of dogs diagnosed with osteosarcoma, one year of age or older. The drug candidate was licensed exclusively from Advaxis, Inc. and is currently in the pivotal trial. Moreover, the private and government organizations such as Veterinary Cancer Society, Petco Foundation, and Animal Cancer Foundation are working together to formulate novel drugs for dogs and cats, which is a major factor expected to propel growth of the pet cancer therapeutics market over the forecast period. However, lack of awareness regarding pet diseases, high cost, and adverse effects of the drugs are the factors restraining pet cancer therapeutics market growth.

Key features of the study:

This report provides in-depth analysis of pet cancer therapeutics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2017 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global pet cancer therapeutics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans

Key companies covered as a part of this study include Aratana Therapeutics, Inc., AB Science, Boehringer Ingelheim International GmbH, Zenoaq, Morphogenesis, Inc., VetDC, Inc., Karyopharm Therapeutics, Inc., Rhizen Pharmaceuticals SA, Regeneus Ltd., Oasmia Pharmaceuticals AB, and Zoetis

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global pet cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the pet cancer therapeutics market

Detailed Segmentation:

  • Global Pet Cancer Therapeutics Market, By Therapy Type:
  • Chemotherapy
  • Targeted Therapy
  • Combination Therapy
  • Immunotherapy
  • Global Pet Cancer Therapeutics Market, By Pet Type:
  • Cat
  • Dog
  • Horse
  • Global Pet Cancer Therapeutics Market, By Mode of Administration:
  • Oral
  • Intravenous
  • Topical
  • Global Pet Cancer Therapeutics Market, By Application:
  • Lymphoma
  • Mast Cell Cancer
  • Melanoma
  • Mammary and Squamous Cell Cancer
  • Others
  • Global Pet Cancer Therapeutics Market, By Geography:
  • North America
  • By Therapy Type:
  • Chemotherapy
  • Targeted Therapy
  • Combination Therapy
  • Immunotherapy
  • By Pet Type:
  • Cat
  • Dog
  • Horse
  • By Mode of Administration:
  • Oral
  • Intravenous
  • Topical
  • By Application:
  • Lymphoma
  • Mast Cell Cancer
  • Melanoma
  • Mammary and Squamous Cell Cancer
  • Others
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Therapy Type:
  • Chemotherapy
  • Targeted Therapy
  • Combination Therapy
  • Immunotherapy
  • By Pet Type:
  • Cat
  • Dog
  • Horse
  • By Mode of Administration:
  • Oral
  • Intravenous
  • Topical
  • By Application:
  • Lymphoma
  • Mast Cell Cancer
  • Melanoma
  • Mammary and Squamous Cell Cancer
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Therapy Type:
  • Chemotherapy
  • Targeted Therapy
  • Combination Therapy
  • Immunotherapy
  • By Pet Type:
  • Cat
  • Dog
  • Horse
  • By Mode of Administration:
  • Oral
  • Intravenous
  • Topical
  • By Application:
  • Lymphoma
  • Mast Cell Cancer
  • Melanoma
  • Mammary and Squamous Cell Cancer
  • Others
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Therapy Type:
  • Chemotherapy
  • Targeted Therapy
  • Combination Therapy
  • Immunotherapy
  • By Pet Type:
  • Cat
  • Dog
  • Horse
  • By Mode of Administration:
  • Oral
  • Intravenous
  • Topical
  • By Application:
  • Lymphoma
  • Mast Cell Cancer
  • Melanoma
  • Mammary and Squamous Cell Cancer
  • Others
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Therapy Type:
  • Chemotherapy
  • Targeted Therapy
  • Combination Therapy
  • Immunotherapy
  • By Pet Type:
  • Cat
  • Dog
  • Horse
  • By Mode of Administration:
  • Oral
  • Intravenous
  • Topical
  • By Application:
  • Lymphoma
  • Mast Cell Cancer
  • Melanoma
  • Mammary and Squamous Cell Cancer
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Therapy Type:
  • Chemotherapy
  • Targeted Therapy
  • Combination Therapy
  • Immunotherapy
  • By Pet Type:
  • Cat
  • Dog
  • Horse
  • By Mode of Administration:
  • Oral
  • Intravenous
  • Topical
  • By Application:
  • Lymphoma
  • Mast Cell Cancer
  • Melanoma
  • Mammary and Squamous Cell Cancer
  • Others
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Aratana Therapeutics, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • AB Science
  • Boehringer Ingelheim International GmbH
  • Zenoaq
  • Morphogenesis, Inc.
  • VetDC, Inc.
  • Karyopharm Therapeutics, Inc.
  • Rhizen Pharmaceutical SA
  • Regeneus Ltd.
  • Oasmia Pharmaceuticals AB
  • Zoetis
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Therapy Type
    • Market Snippet, By Pet Type
    • Market Snippet, By Mode of Administration
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Key Highlights
  • Pipeline Analysis
  • Regulatory Guidelines
  • Initiatives for Prevention of Pet Cancer
  • Approved Targeted Therapies for Pet Cancer
  • Epidemiology

4. Global Pet Cancer Therapeutics Market, By Therapy Type, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017 - 2025
    • Segment Trends
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Targeted Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Combination Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Immunotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)

5. Global Pet Cancer Therapeutics Market, By Pet Type, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017 - 2025
    • Segment Trends
  • Cat
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Dog
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Horse
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)

6. Global Pet Cancer Therapeutics Market, By Mode of Administration, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017 - 2025
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)

7. Global Pet Cancer Therapeutics Market, By Application, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017 - 2025
    • Segment Trends
  • Lymphoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Mast Cell Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Melanoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Mammary and Squamous Cell Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)

8. Global Pet Cancer Therapeutics Market, By Region, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2025
  • North America
    • Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • Aratana Therapeutics, Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • AB Science
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Boehringer Ingelheim International GmbH
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Zenoaq
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Morphogenesis, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • VetDC, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Karyopharm Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Rhizen Pharmaceuticals SA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Regeneus Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Oasmia Pharmaceuticals AB
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Zoetis
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans

  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact

Browse 55 market data tables and 45 figures on "Pet Cancer Therapeutics Market - Global forecast to 2025".

Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
La Merie Publishing
BCC Research